Ricky Henderson, MD
Cardiovascular Disease · Anderson, SCNPI 1487667523
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Medtronic at 44.6% of the total. Among cardiovascular disease clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 816 payments — averaging $63.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$23K
- Boston Scientific$15K
- Abbott$5K
- Biosense Webster, Inc.$3K
- Medical Device Business Services, Inc.$771
- Atricure, Inc.$718
- plus $4K from 27 others
Across 79 payments — averaging $550.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$27K
- Biotronik Inc.$10K
- Medtronic$6K
What the payments were for
- Consulting fees$15,31429%
- Speaking & faculty fees$5,10010%
- Travel & lodging$11,04921%
- Food & beverage$20,63940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 163 | $23,233 |
| Boston Scientific | 192 | $14,743 |
| Abbott | 191 | $5,076 |
| Biosense Webster, Inc. | 57 | $3,108 |
| Medical Device Business Services, Inc. | 4 | $771 |
| Atricure, Inc. | 14 | $718 |
| Biotronik Inc. | 5 | $643 |
| Johnson & Johnson | 26 | $473 |
| Philips North America LLC | 13 | $411 |
| E.r. Squibb & Sons, L.L.C. | 24 | $343 |
| Cardiva Medical, Inc. | 16 | $314 |
| Cvrx, Inc. | 9 | $287 |
| Elutia, Inc. | 13 | $248 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $222 |
| Pfizer | 12 | $202 |
| Edwards Lifesciences | 7 | $171 |
| Lundbeck LLC | 8 | $165 |
| Inari Medical, Inc. | 1 | $141 |
| Novartis | 7 | $122 |
| Impulse Dynamics (USA) Inc. | 5 | $85 |
| Sanofi-aventis U.S. LLC | 6 | $84 |
| Cordis US CORP. | 4 | $74 |
| BD | 3 | $73 |
| Amgen | 3 | $62 |
| Abiomed | 3 | $62 |
| Boehringer Ingelheim | 4 | $56 |
| Merck | 3 | $55 |
| Angiodynamics, Inc. | 1 | $42 |
| Kestra Medical Technology Services, Inc. | 2 | $39 |
| Altathera Pharmaceuticals LLC | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Portola Pharmaceuticals, LLC | 1 | $19 |
| Davol Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$2,633
- WATCHMAN FLX$2,448
- Arctic Front$1,826
- Reveal LINQ$1,716
- AVEIR$1,411
- SPHERE-9$1,292
- INGEVITY$929
- NA$839
- AFFERA MAPPING SYSTEM$578
- GENERAL - THERAPIES$397
- Carto 3$394
- Plexa$394
- Acticor$394
- Rivacor$394
- Edora$394
- Sentus$394
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$327
- Ensite Cardiac Mapping System$302
- WATCHMAN Access System$294
- Micra$281
How this compares
$52,101 in reported general payments places this provider in the 95th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 306 | $291,988 |
| Droxidopa | 49 | $169,020 |
| MultaqDronedarone Hcl | 24 | $42,245 |
| XareltoRivaroxaban | 48 | $37,228 |
| EntrestoSacubitril/Valsartan | 40 | $36,715 |
| Dofetilide | 114 | $27,755 |
| Ranolazine ErRanolazine | 73 | $7,962 |
| Flecainide Acetate | 84 | $4,012 |
| Mexiletine Hcl | 29 | $3,017 |
| ClopidogrelClopidogrel Bisulfate | 359 | $2,793 |
| Midodrine Hcl | 21 | $2,117 |
| Propafenone Hcl ErPropafenone Hcl | 19 | $1,671 |
| Propafenone Hcl | 32 | $1,511 |
| Fludrocortisone Acetate | 38 | $1,413 |
| Metoprolol Succinate | 128 | $1,333 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $202 | $291,988306 claims |
| Sanofi-aventis U.S. LLCMultaq | $84 | $42,24524 claims |
| Johnson & JohnsonXarelto | $473 | $37,22848 claims |
| NovartisEntresto | $122 | $36,71540 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 257 cardiovascular disease providers in South Carolina.
Other cardiovascular disease in Anderson
- John MeehanAnderson$13K
- Brent McLaurinAnderson$11K
- Natalie KelseyAnderson$11K
- John WendtAnderson$10K
- Paul JonesAnderson$9K
- Robert BiedermanCharleston$775K
- Darren SidneyNorth Charleston$129K
- Priyanka BhattacharyaCharleston$107K
- Gregory SanGreenville$88K
- David McNeelyGreenville$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.